This video is part of a three-part series covering new literature that could influence clinical practice. Finerenone has been studied in the setting of HFpEF and I review this topic. More specifically, in this video, I discuss the background of why finerenone may be advantageous over steroidal MRAs including its unique structural characteristics that increase its potency and selectivity. Background studies leading to the FINEARTS-HF trial include the ARTS Trials and FIDELITY Trials, both of which investigate finerenone in different disease states. Finally, the major findings of the FINEARTS-HF trial and its potential to influence clinical practice are covered.

This video was presented by Emma Carlberg, PharmD Candidate.

Did you enjoy this blog post? Subscribers are emailed new blog posts TWICE per week! In addition, you’ll get access to the free giveaways below. Over 6,000 healthcare professionals have subscribed for our FREE Giveaways. Why haven’t you?!

• 30 medication mistakes PDF
• 18+ Page Drug Interaction PDF
• 10 Commandments of Polypharmacy Webinar based on my experiences in clinical practice